Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (Q33515519)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival |
scientific article |
Statements
1 reference
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (English)
1 reference
Jose Baselga
1 reference
K Kian Ang
1 reference
James A Bonner
1 reference
Paul M Harari
1 reference
Jordi Giralt
1 reference
Roger B Cohen
1 reference
Christopher U Jones
1 reference
Ranjan K Sur
1 reference
David Raben
1 reference
Sharon A Spencer
1 reference
Junming Zhu
1 reference
Hagop Youssoufian
1 reference
Eric K Rowinsky
1 reference
10 November 2009
1 reference
1 reference
Identifiers
1 reference